Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of immune-checkpoint inhibitors in lung cancer.
Jain P, Jain C, Velcheti V. Jain P, et al. Among authors: jain c. Ther Adv Respir Dis. 2018 Jan-Dec;12:1753465817750075. doi: 10.1177/1753465817750075. Ther Adv Respir Dis. 2018. PMID: 29385894 Free PMC article. Review.
Afatinib and lung cancer.
Jain P, Khanal R, Sharma A, Yan F, Sharma N. Jain P, et al. Expert Rev Anticancer Ther. 2014 Dec;14(12):1391-406. doi: 10.1586/14737140.2014.983083. Expert Rev Anticancer Ther. 2014. PMID: 25417728 Review.
Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.
Khorrami M, Jain P, Bera K, Alilou M, Thawani R, Patil P, Ahmad U, Murthy S, Stephans K, Fu P, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: jain p. Lung Cancer. 2019 Sep;135:1-9. doi: 10.1016/j.lungcan.2019.06.020. Epub 2019 Jul 5. Lung Cancer. 2019. PMID: 31446979 Free PMC article.
Corrigendum to "Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features" [Lung Cancer 135 (September) (2019) 1-9].
Khorrami M, Jain P, Bera K, Alilou M, Thawani R, Patil P, Ahmad U, Murthy S, Stephans K, Fu P, Velcheti V, Madabhushi A. Khorrami M, et al. Among authors: jain p. Lung Cancer. 2019 Oct;136:156. doi: 10.1016/j.lungcan.2019.08.012. Epub 2019 Aug 21. Lung Cancer. 2019. PMID: 31564290 No abstract available.
Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross-sectional and longitudinal analysis using two large national registries.
Guha A, Jain P, Fradley MG, Lenihan D, Gutierrez JM, Jain C, de Lima M, Barnholtz-Sloan JS, Oliveira GH, Dowlati A, Al-Kindi S. Guha A, et al. Among authors: jain p, jain c. Cancer Med. 2021 Jun;10(12):3862-3872. doi: 10.1002/cam4.3938. Epub 2021 May 13. Cancer Med. 2021. PMID: 33982883 Free PMC article.
Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States.
Jain P, Gutierrez Bugarin J, Guha A, Jain C, Patil N, Shen T, Stanevich I, Nikore V, Margolin K, Ernstoff M, Velcheti V, Barnholtz-Sloan J, Dowlati A. Jain P, et al. Among authors: jain c. ESMO Open. 2021 Oct;6(5):100252. doi: 10.1016/j.esmoop.2021.100252. Epub 2021 Aug 27. ESMO Open. 2021. PMID: 34461483 Free PMC article.
Corrigendum to 'Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States': [ESMO Open Volume 6, Issue 5, October 2021, 100252].
Jain P, Gutierrez Bugarin J, Guha A, Jain C, Patil N, Shen T, Stanevich I, Nikore V, Margolin K, Ernstoff M, Velcheti V, Barnholtz-Sloan J, Dowlati A. Jain P, et al. Among authors: jain c. ESMO Open. 2021 Dec;6(6):100286. doi: 10.1016/j.esmoop.2021.100286. Epub 2021 Oct 19. ESMO Open. 2021. PMID: 34678570 Free PMC article. No abstract available.
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers.
Braman N, Prasanna P, Bera K, Alilou M, Khorrami M, Leo P, Etesami M, Vulchi M, Turk P, Gupta A, Jain P, Fu P, Pennell N, Velcheti V, Abraham J, Plecha D, Madabhushi A. Braman N, et al. Among authors: jain p. Clin Cancer Res. 2022 Oct 14;28(20):4410-4424. doi: 10.1158/1078-0432.CCR-21-4148. Clin Cancer Res. 2022. PMID: 35727603 Free PMC article.
3,421 results